trending Market Intelligence /marketintelligence/en/news-insights/trending/4t-zvLlZ6dIKX_LCfpjnbA2 content esgSubNav
In This List

Tianshui Zhongxing Bio-technology Q1 profit climbs 78.6% YOY

Blog

Capital Markets Activity Infographic: SPAC Volume Rises in Q3; Equity Issuance Drops but Remains Strong in Several Sectors

Blog

Asset Owner Perspectives on Climate Change Measurement, Management, and Reporting in Australia

Blog

How Financial Institutions are Managing Exposure to U.S. Municipals

Blog

Insight Weekly: Global stock performance; hydrogen pilot projects; Powell's Fed future unsure


Tianshui Zhongxing Bio-technology Q1 profit climbs 78.6% YOY

Tianshui Zhongxing Bio-technology Co. Ltd. said its first-quarter normalized net income was 16 fen per share, a gain of 28.0% from 13 fen per share in the year-earlier period.

Normalized net income, which excludes unusual gains or losses on a pre- and after-tax basis, was 52.2 million yuan, a gain of 78.6% from 29.3 million yuan in the year-earlier period.

The normalized profit margin increased to 29.2% from 22.6% in the year-earlier period.

Total revenue rose 41.1% on an annual basis to 182.7 million yuan from 129.5 million yuan, and total operating expenses climbed 21.7% on an annual basis to 97.4 million yuan from 80.0 million yuan.

Reported net income rose 85.1% on an annual basis to 86.3 million yuan, or 27 fen per share, from 46.6 million yuan, or 20 fen per share.

As of April 22, US$1 was equivalent to 6.50 yuan.